(Q35124160)

6 August 2017

Routine use of approximately 60 Gy once-daily thoracic irradiation for patients with limited-stage small-cell lung cancer (English)

1 reference

6 August 2017

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(02)04493-0

31 December 2023

author name string

Jeffrey Crawford

6

1 reference

6 August 2017

Keith L. Miller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12738309

31 December 2023

Lawrence B. Marks

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12738309

31 December 2023

Gregory S. Sibley

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12738309

31 December 2023

Robert W. Clough

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12738309

31 December 2023

Jennifer L. Garst

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12738309

31 December 2023

Timothy D. Shafman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12738309

31 December 2023

language of work or name

English

0 references

publication date

1 June 2003

1 reference

full work available at URL

6 August 2017

https://api.elsevier.com/content/article/PII:S0360301602044930?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S0360-3016(02)04493-0

https://api.elsevier.com/content/article/PII:S0360301602044930?httpAccept=text/plain

31 December 2023

1 reference

DOI

https://api.crossref.org/works/10.1016/S0360-3016(02)04493-0

International Journal of Radiation Oncology Biology Physics

31 December 2023

published in

1 reference

6 August 2017

56

1 reference

6 August 2017

2

1 reference

6 August 2017

355-359

1 reference

6 August 2017

Cancer statistics, 2001

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904493-0

7 January 2021

Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904493-0

7 January 2021

Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904493-0

7 January 2021

Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904493-0

7 January 2021

Improved local control of thoracic disease in small cell lung cancer with higher dose thoracic irradiation and cyclic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904493-0

7 January 2021

A meta-analysis of thoracic radiotherapy for small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904493-0

7 January 2021

Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904493-0

7 January 2021

Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904493-0

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904493-0

7 January 2021

Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904493-0

7 January 2021

Five-year follow-up of the Medical Research Council comparative trial of surgery and radiotherapy for the primary treatment of small-celled or oat-celled carcinoma of the bronchus

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904493-0

7 January 2021

Randomized trial of radiotherapy to the thorax in limited small-cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904493-0

7 January 2021

Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904493-0

7 January 2021

Improved methodology for analyzing local and distant recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904493-0

7 January 2021

Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904493-0

7 January 2021

Dosimetric predictors of radiation-induced lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904493-0

7 January 2021

Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904493-0

7 January 2021

Clinical and dosimetric predictors of radiation-induced esophageal toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904493-0

7 January 2021

Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904493-0

7 January 2021

Randomized phase III trial of radiation treatment +/- amifostine in patients with advanced-stage lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904493-0

7 January 2021

Identifiers

DOI

1 reference

6 August 2017

1 reference